Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:      
Net income (loss) $ (226,552) $ (114,311) $ (27,264)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
Depreciation and amortization expense 32,639 11,692 10,724
Amortization of debt issuance costs and discount 2,282 857 608
Equity-based compensation expense 58,990 11,326 8,658
(Gain) loss on sale of joint ventures 0 (1,303) 0
Loss on extinguishment of debt 996 0 0
(Gain) loss on change in fair value of committed equity facility 0 0 255
(Gain) loss on change in fair value of warrants (16,109) 51,960 2,011
Deferred provision (benefit) for income taxes (24,901) (1,803) (925)
Impairment expense 34,685 0 0
Income from equity method investments 0 0 (245)
Non-cash lease expense 488 227 327
Non-cash interest expense 0 0 525
Purchase accounting fair value adjustment related to inventory 13,645 0 0
Other (1,470) 2,050 (238)
Changes in assets and liabilities:      
(Increase) decrease in accounts receivable (2,321) 14,670 (5,562)
(Increase) decrease in contract assets 863 (7,138) (5,442)
(Increase) decrease in inventory (6,652) (734) (44)
(Increase) decrease in prepaid expenses and other assets (4,386) (1,793) 229
Increase (decrease) in accounts payable and accrued expenses (11,660) 4,365 (3,280)
Increase (decrease) in deferred revenue (33,980) 3,207 22,736
Increase (decrease) in operating lease liabilities (232) (342) (325)
Increase (decrease) in other liabilities 6,344 9,722 (960)
Increase (decrease) in notes payable to sellers 0 0 (557)
Net cash provided by (used in) operating activities (177,331) (17,348) 1,231
Cash flows from investing activities:      
Acquisition of businesses, net of cash acquired (151,791) (881) 0
Net proceeds from sale of joint ventures 0 4,598 0
Purchases of property, plant and equipment (13,479) (6,399) (5,620)
Purchase of intangible assets (9,801) (4,517) (2,707)
Net cash provided by (used in) investing activities (175,071) (7,199) (8,327)
Cash flows from financing activities:      
Proceeds received from debt 191,131 45,971 36,696
Repayments of debt (234,165) (8,863) (26,683)
Payment of debt issuance fees (105) (780) (163)
Repayment of finance leases (534) (479) (395)
Proceeds from (repayment of) third-party advances (7,820) 7,820 0
Proceeds from issuance of common stock 518,370 2,669 1,241
Payment of equity issuance costs (1,749) 0 (571)
Payments of issuance costs related to convertible preferred stock 0 0 (52)
Shares repurchased for settlement of employee tax withholdings on share-based awards (3,769) (2,622) (570)
Payment of contingent earnout 0 0 (443)
Repurchase of convertible preferred stock (63,863) 0 0
Net cash provided by (used in) financing activities 397,496 43,716 9,060
Effect of foreign currency rate changes on cash, cash equivalents and restricted cash 1,018 (376) (2)
Net increase (decrease) in cash, cash equivalents and restricted cash 46,112 18,793 1,962
Cash, cash equivalents and restricted cash at beginning of period 49,071 30,278 28,316
Cash, cash equivalents and restricted cash at end of period $ 95,183 $ 49,071 $ 30,278